Investigation and management of uveitis

BMJ (Online)

Volumn 341, Issue 7777, 2010, Pages 821-826

  Guly, Catherine M ^a   Forrester, John V ^b  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BEVACIZUMAB; CORTICOSTEROID; CYCLOSPORIN A; FLUOCINOLONE ACETONIDE; INFLIXIMAB; METHOTREXATE; MYCOPHENOLIC ACID; PREDNISOLONE; PREDNISOLONE ACETATE; RANIBIZUMAB; STEROID; TACROLIMUS;

ALLERGIC CONJUNCTIVITIS; ANKYLOSING SPONDYLITIS; ANTIBIOTIC THERAPY; ARTHROPATHY; BEHCET DISEASE; CATARACT; CLOSED ANGLE GLAUCOMA; CONJUNCTIVITIS; CORNEA EROSION; CORNEA ULCER; CYTOMEGALOVIRUS INFECTION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG IMPLANT; DRUG MEGADOSE; DRUG SUBSTITUTION; ENDOPHTHALMITIS; ENTERITIS; EPIPHORA; EPISCLERITIS; EYE DISCHARGE; EYE SYNECHIA; FLUORESCENCE ANGIOGRAPHY; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAOCULAR PRESSURE; JUVENILE RHEUMATOID ARTHRITIS; KIDNEY DISEASE; LYMPHOMA; MULTIPLE SCLEROSIS; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PHOTOPHOBIA; PRIORITY JOURNAL; PRURITUS; REITER SYNDROME; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA CYSTOID EDEMA; RETINA MACULA DEGENERATION; REVIEW; SARCOIDOSIS; SCLERITIS; SCREENING TEST; SIDE EFFECT; SLIT LAMP; STEROID THERAPY; SYPHILIS; TOXOCARIASIS; TOXOPLASMOSIS; TUBERCULOSIS; UVEITIS; VARICELLA ZOSTER VIRUS; VISUAL ACUITY; VITRECTOMY; VOGT KOYANAGI SYNDROME; VOMITING;

BIOLOGICAL FACTORS; CHRONIC DISEASE; DIAGNOSTIC IMAGING; EYE INFECTIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; OFF-LABEL USE; OPHTHALMIC SOLUTIONS; PHYSICAL EXAMINATION; STEROIDS; UVEITIS; VISION DISORDERS;

EID: 77958119728     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c4976     Document Type: Review

References (28)

1. Suttorp-Schulten MS, Rothova A. The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol 1996;80:844-8. (Pubitemid 26345317)
2. Durrani OM, Tehrani NN, Marr JE, Moradi P, Stavrou P, Murray PI. Degree, duration and causes of visual loss in uveitis. Br J Ophthalmol 2004;88:1159-62. (Pubitemid 39141376)
3. Rothova A, Buitenhuis HJ, Meenken C, Brinkman CJ, Linssen A, Alberts C, et al. Uveitis and systemic disease. Br J Ophthalmol 1992;76:137-41.
4. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 2005;140:509-16.
5. Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A. Causes and frequency of blindness in patients with ocular inflammatory disease. Br J Ophthalmol 1996;80:332-6. (Pubitemid 26113585)
6. Maini R, O'Sullivan J, Reddy A, Watson S, Edelston C. The risk of complications of uveitis in a district hospital cohort. Br J Ophthalmol 2004;88:512-7. (Pubitemid 38437872)
7. Dick AD, Okada AA, Forrester JV. Practical manual of intraocular inflammation. Informa Healthcare, 2008.
8. Gilbert RE, Harden M, Stanford M. Antibiotics versus control for toxoplasma retinochoroiditis. Cochrane Database Syst Rev 2002;1:CD002218.
9. Islam N, Pavesio C. Uveitis (acute anterior). BMJ Clin Evid 2007;12:705.
10. Loteprednol Etabonate US Uveitis Study Group. Controlled evaluation of loteprednol etabonate and prednisolone acetate in the treatment of acute anterior uveitis. Am J Ophthalmol 1999;127:537-44.
11. Van Kooij B, Rothova A. The pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular oedema. Ocul Immunol Inflamm 2006;14:73-85.
12. Pavesio C, Zierhut M, Bairi K, Comstock TL, Usner DW. Evaluation of a fluocinolone acetonide steroid implant versus standard systemic therapy in noninfectious posterior uveitis. Ophthalmology 2010;117:567-75.
13. Mansour AM, Arelavo JF, Ziemssen F, Mehio-Sibai A, Mackensen F, Adan A. Long term visual outcomes of intravitreal bevacizumab in inflammatory ocular neovascularisation. Am J Ophthalmol 2009;148:310-6.
14. Jabs DA, Rosenbaum JT, Foster CS, Holland GN, Jaffe GJ, Louie JS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 2000;130:492-513.
15. Yazici H, Pazarli H, Barnes CG, Tûzûn Y, Ozyazgan Y, Silman A, et al. A controlled trial of azathioprine in Behçet's syndrome. N Engl J Med 1990;322:281-5. (Pubitemid 20046329)
16. Nussenblatt RB, Palestine AG, Chan CC, Stephens G Jr, Mellow SD, Green SB. Randomized, double-masked study of cyclosporine compared to prednisolone in the treatment of endogenous uveitis. Am J Ophthalmol 1991;112:138-46.
17. Murphy CC, Greiner K, Plskova J, Duncan L, Frost NA, Forrester JV, et al. Cyclosporine vs tacrolimus therapy for posterior and intermediate uveitis. Arch Ophthalmol 2005;123;634-41. (Pubitemid 40695511)
18. Daniel E, Thorne JE, Newcomb CW, Pujari SS, Kaçmaz RO, Levy-Clarke GA, et al. Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol 2010;149:423-32.
19. Gangaputra S, Newcomb CW, Liesegang TL, Kaçmaz RO, Jabs DA, Levy-Clarke GA. Methotrexate for ocular inflammatory diseases. Ophthalmology 2009;116:2188-98.
20. Yamada Y, Sugita S, Tanaka H, Kamoi K, Kawaguchi T, Mochizuki M. Comparison of infliximab versus ciclosporin during the initial 6-month treatment period in Behçet disease. Br J Ophthalmol 2010;94:284-8.
21. Lee RWJ, Dick ADD. Treat early and embrace the evidence in favour of anti-TNF-α therapy for Behcet's uveitis. Br J Ophthalmol 2010;94:269-270.
22. Diaz-Llopis M, García-Delpech S, Salom D, Udaondo P, Hernández-Garfella M, Bosch-Morell F, et al. Adalimumab therapy for refractory uveitis: a pilot study. J Ocul Pharmacol Ther 2008;24:351-61. (Pubitemid 351733224)
23. Suhler EB, Smith JR, Giles TR, Lauer AK, Wertheim MS, Kurz DE, et al. Infliximab therapy for refractory uveitis: 2-year results of a prospective trial. Arch Ophthalmol 2009;127:819-22.
24. Kötter I, Zierhut M, Eckstein AK, Vonthein R, Ness T, Gûnaydin I, et al. Human recombinant interferon alpha-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis. Br J Ophthalmol 2003;87:423-31. (Pubitemid 36399030)
25. Plskova J, Greiner K, Forrester JV. Interferon-á as an effective treatment for non-infectious posterior uveitis and panuveitis. Am J Ophthalmol 2007;144:55-61. (Pubitemid 46963200)
26. Deuter CME, Koetta I, Guenaydin I, Stuebiger N, Zierhut M. Interferon alpha 2-A: a new treatment option for long lasting refractory cystoid macular edema in uveitis. A pilot study. Retina 2006;26:786-91. (Pubitemid 44386101)
27. Kempen JH, Daniel E, Dunn JP, Foster CS, Gangaputra S, Hanish A, et al. Overall and cancer related mortality in patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study. BMJ 2009;339:b2480.
28. Royal College of Ophthalmologists, British Society for Paediatric and Adolescent Rheumatology. Guidelines for screening for uveitis in juvenile idiopathic arthritis (JIA). 2006. www.rcophth.ac.uk/docs/publications/ JuvenileArthritis.pdf.